论文部分内容阅读
目的 评价癌肿姑息切除在中晚期肝癌治疗中的作用。方法 把我院肝胆外科于 1996年 3月至 1999年 6月收治的 86例 (术中证实不能行根治性切除者 )中晚期肝癌患者随机分成两组 ,治疗组行癌肿大部分切除 +肝动脉置管埋泵化疗等综合治疗 ,对照组剖腹行肝动脉置管埋泵化疗等综合治疗。结果 治疗组及对照组的 AFP下降率和半年、1年、3年的生存率分别为 6 1.1%(2 2 / 36 )、88.4% (38/ 43)、5 9.4% (19/ 32 )、44 .4% (8/ 18) ,31.5 % (12 / 38)、6 7.4% (2 9/ 43)、33.3% (12 / 36 )、11.8% (2 / 17) ,两者比较P<0 .0 5 ,差异有显著性。结论 癌肿姑息切除有助于提高中晚期肝癌患者生命质量
Objective To evaluate the role of palliative resection of cancer in the treatment of advanced liver cancer. Methods Eighty-six patients with hepatic and gallbladder surgery admitted to our hospital from March 1996 to June 1999 were randomly divided into two groups. The treatment group received most of the cancer resection and liver. Arterial catheter embedment pump chemotherapy and other comprehensive treatment, control group laparotomy, hepatic artery catheterization buried pump chemotherapy and other comprehensive treatment. Results The AFP decline rate in the treatment group and the control group was 6 1.1% (22/36), 88.4% (38/43), 5 9.4% (19/32), and 6 months, 1 year, and 3 years respectively. 44.4% (8/18), 31.5 % (12 / 38), 6 7.4% (2 9/ 43), 33.3% (12 / 36), 11.8% (2 / 17), comparing P<0 .0 5, the difference is significant. Conclusion Palliative resection of cancer can improve the quality of life of patients with advanced liver cancer